SIGA Technologies Inc

NASDAQ • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/30/2026

Company Profile

IndustryDrug Manufacturers - Specialty & Generic

SectorHealthcare

ExchangeNASDAQ

Market Capitalization229.92 mln

Float41.13 mln

Earnings Date11/05/2026

Business Description

SIGA Technologies is a New York-based pharmaceutical company founded in 1995, specializing in medicines designed to protect public health against serious biological threats. Its primary product, TPOXX, is an antiviral treatment developed to combat smallpox, a disease caused by the variola virus. The company sells its products primarily within the United States.

Key Fundamentals

EPS-0.04

ROE-1.50

RPS0.75

ROIC-10.07

ROA-1.29

EBITDA, mln-4.92

EV / EBITDA-25.87

EV / EBIT-23.10

Revenue, mln53.66

EV / Revenue2.37

Quote Details

Last 3.04

Change -0.14 (-4.4%)

Open 3.18

Volume 503,984

Turnover 1,532,111

Average Volume 510,327

Financial Ratios

Pre-Tax Profit Margin-10

Leverage Ratio1.06

Current Ratio21.72

Price / Book1.48

Price / Tangible Book1.48

Debt / Equity0.00

Price / Sales4.52

PEG Ratio3.37

Financial Strength

Altman Z-Score14.89

Piotroski F-Score 2 / 9

Beneish M-Score-0.06

Price to Intrinsic Value0.40

Shiller PE Ratio3.27

Short Ratio5.13

Short % of Float7.74

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	-2.56%	25 / 100
1 Month	-9.25%	30 / 100
2 Months	-1.94%	48 / 100
6 Months	-33.91%	19 / 100
1 Year	-57.72%	16 / 100

SIGA Technologies Inc

Company Profile

Piotroski F-Score

Beneish M-Score

Relative Strength

Debt / Equity